1.255
price down icon14.04%   -0.205
after-market 시간 외 거래: 1.31 0.055 +4.38%
loading

Pepgen Inc 주식(PEPG)의 최신 뉴스

pulisher
Apr 02, 2025

PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference - BioSpace

Apr 02, 2025
pulisher
Apr 01, 2025

PepGen Announces Appointment of Two New Directors to its Board - BioSpace

Apr 01, 2025
pulisher
Mar 31, 2025

PepGen Inc. Expands Board with New Appointments - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

PepGen names two new directors to board - TipRanks

Mar 31, 2025
pulisher
Mar 28, 2025

PepGen CMO Mellion resigns, effective April 4 By Investing.com - Investing.com Australia

Mar 28, 2025
pulisher
Mar 28, 2025

PepGen CMO Mellion resigns, effective April 4 - Investing.com

Mar 28, 2025
pulisher
Mar 26, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen IncPEPG - Bluefield Daily Telegraph

Mar 26, 2025
pulisher
Mar 18, 2025

PEPG ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of PepGen Inc. Shareholders Who Lost Money - ACCESS Newswire

Mar 18, 2025
pulisher
Mar 10, 2025

PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference - Business Wire

Mar 10, 2025
pulisher
Mar 10, 2025

PepGen Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsPEPG - ACCESS Newswire

Mar 10, 2025
pulisher
Mar 05, 2025

PepGen Inc. Faces Clinical Trial Challenges and Competitive Pressures Leading to Sell Rating - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

What Do Analysts Think Will Happen To PepGen Inc (NASDAQ: PEPG) - Stocks Register

Mar 05, 2025
pulisher
Mar 05, 2025

PepGen pauses Phase II DMD trial to review safety data - Clinical Trials Arena

Mar 05, 2025
pulisher
Mar 04, 2025

PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen To Voluntarily Pause Mid-Stage Duchenne Muscular Dystrophy Study, Stock Falls - Benzinga

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Boston biotech's stock drops after Duchenne trial pause - The Business Journals

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen to pause CONNECT2-EDO51 study - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen slumps after pausing mid-stage study of Duchenne drug - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen pauses phase 2 DMD study to review earlier trial data - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD -March 04, 2025 at 08:18 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen stock slides after trial pause (PEPG:NASDAQ) - Seeking Alpha

Mar 04, 2025
pulisher
Mar 04, 2025

Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen to Participate in Upcoming Investor Conferences - Business Wire

Mar 04, 2025
pulisher
Mar 04, 2025

AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - Asianet Newsable

Mar 04, 2025
pulisher
Mar 03, 2025

PepGen Sees Fastest Weekly Retail Following Growth Among Biotech Stocks: What's Behind The Buzz? - Asianet Newsable

Mar 03, 2025
pulisher
Mar 03, 2025

PepGen (PEPG) to Release Quarterly Earnings on Wednesday - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

Q1 Earnings Estimate for PepGen Issued By HC Wainwright - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Q1 Earnings Forecast for PepGen Issued By Leerink Partnrs - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

PepGen Inc. (NASDAQ:PEPG) Stock Analysis: Earnings Estimates, Analyst Ratings, and Market Performance - HPBL

Feb 28, 2025
pulisher
Feb 28, 2025

What is HC Wainwright’s Estimate for PepGen FY2025 Earnings? - Defense World

Feb 28, 2025
pulisher
Feb 28, 2025

PepGen (PEPG) Shares Rally In Extended Session - Stocks Telegraph

Feb 28, 2025
pulisher
Feb 28, 2025

Wedbush Weighs in on PepGen’s Q1 Earnings (NASDAQ:PEPG) - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

HC Wainwright Reiterates Buy Rating for PepGen (NASDAQ:PEPG) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Stock market news: Binah Capital Group +184.15%, PepGen +35.25% among top gainers during midday trading - Business Upturn

Feb 27, 2025
pulisher
Feb 27, 2025

Promising Prospects for PepGen Inc.: Buy Rating Affirmed Amid Positive DM1 Treatment Developments - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

What is HC Wainwright’s Estimate for PepGen Q1 Earnings? - Defense World

Feb 27, 2025
pulisher
Feb 26, 2025

PepGen CFO Noel Donnelly sells $2,565 in stock By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

PepGen general counsel DeLena sells $2,405 in stock - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

PepGen general counsel DeLena sells $2,405 in stock By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

PepGen CFO Noel Donnelly sells $2,565 in stock - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

PepGen reports positive initial data from Phase I DM1 therapy trial - MSN

Feb 26, 2025
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
자본화:     |  볼륨(24시간):